Compare Fiverr International Ltd (FVRR) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiverr International Ltd vs BIO-TECHNE Corp — how do they compare? Fiverr International Ltd trades at $8.84 (market cap $326.79M), while BIO-TECHNE Corp trades at $72.18 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 34.4× Fiverr International Ltd's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Fiverr International Ltd pays none. Which is the better fit depends on your goals.
| FVRR | TECH | |
|---|---|---|
Market Cap | $326.79M | $11.24B |
Sector | Industrials | Health |
52-Week High | $26.67 | $72.29 |
52-Week Low | $8.93 | $43.31 |
Enterprise Value | $79.18M | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fiverr International (FVRR) trades at $9.42, up 2.39% on the day, but remains near its 52-week low amid bearish technical signals. The stock shows weak earnings momentum with Q2 2026 misses and lowered 2026 guidance due to AI disruption compressing demand for freelance services. Valuation ratios appear attractive with P/E of 11.63 and P/S of 0.83, while profitability metrics show modest improvement with net income margin at 7.18% for 2025.
The outlook is cautious with significant headwinds from AI adoption threatening Fiverr's core business model. Near-term risks include declining active buyers and revenue pressure, though current valuations may offer contrarian appeal if the company successfully adapts to AI challenges. Wall Street sentiment is neutral with 76% hold ratings and a $10.70 consensus price target suggesting limited upside.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
